2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2005
News and Resources
2011 Releases
12/09/2022 - Opexa Therapeutics to Present at the Oppenheimer 22nd Annual Healthcare Conference
11/02/2022 - Opexa Elects Gail Maderis to Board of Directors
09/19/2011 - Opexas CEO Invited to Present at Two Cell Therapy Forums in Asia During September, 2011
09/12/2021 - Dr. Mark Freedman to Join Opexas Scientific Advisory Board
06/28/2011 - Opexa Executes Service Agreement with Blood Group Alliance, Inc.
06/02/2022 - Opexa Initiates Discussions with Health Canada in Pre-CTA Meeting
05/17/2011 - Opexa Executes Strategic Agreement with the American Red Crosss
05/06/2022 - Opexa Therapeutics Reports First Quarter 2011 Financial Results
04/15/2011 - Opexa Presents Tovaxin Data at American Academy of Neurology 2011 Annual Meeting
03/23/2011 - Opexa to Present Tovaxin Data at 2011 American Academy of Neurology Annual Meeting
02/22/2011 - Opexa CEO Invited as Keynote Speaker at Cell Therapy Conference in Beijing, China
02/09/2022 - Opexa to Present at the 13th Annual BIO CEO & Investor Conference on February 14, 2022